Ichor Holdings, Ltd. — FY2023 Form 10-K
Reporting period: Fiscal year ended December 29, 2023 (52 weeks). This is an annual filing, not a standalone fourth-quarter report. Ichor designs and manufactures gas and chemical delivery subsystems and components primarily for semiconductor capital-equipment OEMs.
Financial performance
| Metric | FY2023 | FY2022 |
|---|---|---|
| Revenue | $811.1 million | $1,280.1 million |
| Gross profit / margin | $103.4 million / 12.7% | $211.9 million / 16.6% |
| Operating income (loss) / margin | $(10.9) million / (1.3)% | $85.8 million / 6.7% |
| Net income (loss) | $(43.0) million | $72.8 million |
| Diluted EPS | $(1.47) | $2.51 |
| Non-GAAP net income / diluted EPS | $12.3 million / $0.42 | $104.9 million / $3.62 |
| Cash from operations | $57.6 million | $31.5 million |
| Capital expenditures | $15.5 million | $29.4 million |
Cash and cash equivalents were $80.0 million at year-end, down $6.5 million. Total debt principal was $250.0 million ($135.0 million term loan and $115.0 million revolving facility); $7.5 million was current. The facilities mature in October 2026 and bear variable rates; the year-end rate was 7.58%. Management said cash, credit facilities and operating cash flow should fund current obligations for at least the next 12 months and beyond. A 100-basis-point rate change would alter annualized interest expense by approximately $2.5 million.
Material changes and drivers
- Revenue fell 36.6%, primarily as semiconductor equipment customers reduced spending during an industry downturn.
- Gross margin contracted 390 basis points, reflecting lower factory utilization, a less favorable component-sales mix and approximately 60 basis points of pressure from excess and obsolete inventory charges.
- Inventory write-downs were $9.8 million, compared with $5.0 million in FY2022; the year-end inventory reserve was $28.4 million.
- Interest expense rose 75.3% to $19.4 million as the average borrowing rate increased to 6.80% from 3.37%, despite lower average borrowings.
- Income tax expense was $11.9 million despite a pretax loss. A $11.1 million valuation allowance against U.S. federal and state deferred tax assets was a principal factor.
- Operating cash flow benefited from working-capital reductions, including lower accounts receivable and inventory. Debt repayments were $52.5 million net; capital spending declined from FY2022.
Outlook, risks and notable items
- Management described near-term conditions as challenging but expects semiconductor and equipment demand to return to growth over the longer term. The filing provides no numerical revenue or earnings guidance.
- Cost-reduction initiatives continued through 2023; the company recorded $2.3 million of severance charges in FY2023.
- Customer concentration is significant: Applied Materials, Lam Research and ASML together represented 82% of FY2023 sales. Orders are generally purchase-order based, with no long-term minimum-volume commitments.
- Risks include semiconductor-market cyclicality, customer pricing leverage, supply-chain and order volatility, and U.S. export controls affecting China-related business. The company noted potential revenue effects if export licenses are delayed or denied.
- Debt covenants include a minimum fixed-charge coverage ratio and maximum leverage ratio; variable-rate borrowing adds interest-rate exposure. The company does not anticipate cash dividends for the foreseeable future.
- KPMG issued unqualified opinions on the financial statements and internal control over financial reporting. A previously identified IT general-controls material weakness was reported remediated as of year-end. No material litigation or regulatory proceeding was reported.
Key facts investors should verify
- Whether customer demand, revenue and factory utilization recover, and how quickly margins improve.
- Inventory quality and reserve adequacy, given elevated write-downs and inventory of $245.9 million.
- Debt covenant headroom, refinancing needs before the October 2026 maturity, and sensitivity to floating rates.
- Export-license developments and the effect of China-related restrictions on sales and supply chains.
- Whether the U.S. deferred-tax valuation allowance remains appropriate and how future taxable income affects reported results.
- Whether remediated IT controls continue to operate effectively and whether customer concentration changes.